ArticleRSC advances2023
Durable composites by vulcanization of oleyl-esterified lignin.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 25 citations in OpenAlex.
- Upcycling Printed Circuit Board E-Waste to High-Strength, Multifunctional, and Reprocessable Sulfur Composites via Thiocracking.ChemSusChem · 2026Article
- Tailoring Polymer Properties Through Lignin Addition: A Recent Perspective on Lignin-Derived Polymer Modifications.Molecules (Basel, Switzerland) · 2025Review
- Static and Dynamic Assessments of a Sulfur-Triglyceride Composite for Antimicrobial Surface Applications.Molecules (Basel, Switzerland) · 2025Article
- The Influence of the Comonomer Ratio and Reaction Temperature on the Mechanical, Thermal, and Morphological Properties of Lignin Oil-Sulfur Composites.Molecules (Basel, Switzerland) · 2024Article
- Characterization of balsam sulfide via pyrolysis-gas chromatography-mass spectrometry/sulfur chemiluminescence detection and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Productive utilization of lignocellulosic biomass is critical to the continued advancement of human civilization. Whereas the cellulose component can be efficiently upconverted to automotive fuel-grade ethanol, the lack of upconversion methods for the lignin component constitutes one of the grand challenges facing science. Lignin is an attractive feedstock for structural applications, in which its highly-crosslinked architecture can endow composite structures with high strengths. Prior work suggests that high-strength composites can be prepared by the reaction of olefin-modified lignin with sulfur. Those studies were limited to ≤5 wt% lignin, due to phase-separation of hydrophilic lignin from hydrophobic sulfur matrices. Herein we report a protocol to increase lignin hydrophobicity and thus its incorporation into sulfur-rich materials. This improvement is affected by esterifying lignin with oleic acid prior to its reaction with sulfur. This approach allowed preparation of esterified lignin-sulfur (ELS) composites comprising up to 20 wt% lignin. Two reaction temperatures were employed such that the reaction of ELS with sulfur at 180 °C would only produce S-C bonds at olefinic sites, whereas the reaction at 230 °C would produce C-S bonds at both olefin and aryl sites. Mechanistic analyses and microstructural characterization elucidated two ELS composites having compressive strength values (>20 MPa), exceeding the values observed with ordinary Portland cements. Consequently, this new method represents a way to improve lignin utilization to produce durable composites that represent sustainable alternatives to Portland cements.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.